Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar

Eunji Kim(Samsung (South Korea)), Beom Chan Kim(Samsung (South Korea))

Ophthalmology and Therapy

January 27, 2022

10.1007/s40123-022-00453-7

Cited by 16

Related Papers

No related papers found

Powered by citation graph analysis